Hyesun Jang1, Ted M Ross1,2. 1. Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States of America. 2. Department of Infectious Diseases, University of Georgia, Athens, GA, United States of America.
Abstract
BACKGROUND: A systemic evaluation of the antigenic differences of the H7 influenza hemagglutinin (HA) proteins, especially for the viruses isolated after 2016, are limited. The purpose of this study was to investigate the antigenic differences of major H7 strains with an ultimate aim to discover H7 HA proteins that can elicit protective receptor-binding antibodies against co-circulating H7 influenza strains. METHOD: A panel of eight H7 influenza strains were selected from 3,633 H7 HA amino acid sequences identified over the past two decades (2000-2018). The sequences were expressed on the surface of virus like particles (VLPs) and used to vaccinate C57BL/6 mice. Serum samples were collected and tested for hemagglutination-inhibition (HAI) activity. The vaccinated mice were challenged with lethal dose of H7N9 virus, A/Anhui/1/2013. RESULTS: VLPs expressing the H7 HA antigens elicited broadly reactive antibodies each of the selected H7 HAs, except the A/Turkey/Italy/589/2000 (Italy/00) H7 HA. A putative glycosylation due to an A169T substitution in antigenic site B was identified as a unique antigenic profile of Italy/00. Introduction of the putative glycosylation site (H7 HA-A169T) significantly altered the antigenic profile of HA of the A/Anhui/1/2013 (H7N9) strain. CONCLUSION: This study identified key amino acid mutations that result in severe vaccine mismatches for future H7 epidemics. Future universal influenza vaccine candidates will need to focus on viral variants with these key mutations.
BACKGROUND: A systemic evaluation of the antigenic differences of the H7 influenza hemagglutinin (HA) proteins, especially for the viruses isolated after 2016, are limited. The purpose of this study was to investigate the antigenic differences of major H7 strains with an ultimate aim to discover H7 HA proteins that can elicit protective receptor-binding antibodies against co-circulating H7 influenza strains. METHOD: A panel of eight H7 influenza strains were selected from 3,633 H7 HA amino acid sequences identified over the past two decades (2000-2018). The sequences were expressed on the surface of virus like particles (VLPs) and used to vaccinate C57BL/6 mice. Serum samples were collected and tested for hemagglutination-inhibition (HAI) activity. The vaccinated mice were challenged with lethal dose of H7N9 virus, A/Anhui/1/2013. RESULTS: VLPs expressing the H7 HA antigens elicited broadly reactive antibodies each of the selected H7 HAs, except the A/Turkey/Italy/589/2000 (Italy/00) H7 HA. A putative glycosylation due to an A169T substitution in antigenic site B was identified as a unique antigenic profile of Italy/00. Introduction of the putative glycosylation site (H7 HA-A169T) significantly altered the antigenic profile of HA of the A/Anhui/1/2013 (H7N9) strain. CONCLUSION: This study identified key amino acid mutations that result in severe vaccine mismatches for future H7 epidemics. Future universal influenza vaccine candidates will need to focus on viral variants with these key mutations.
Authors: Tommy Tsan-Yuk Lam; Boping Zhou; Jia Wang; Yujuan Chai; Yongyi Shen; Xinchun Chen; Chi Ma; Wenshan Hong; Yin Chen; Yanjun Zhang; Lian Duan; Peiwen Chen; Junfei Jiang; Yu Zhang; Lifeng Li; Leo Lit Man Poon; Richard J Webby; David K Smith; Gabriel M Leung; Joseph S M Peiris; Edward C Holmes; Yi Guan; Huachen Zhu Journal: Nature Date: 2015-03-11 Impact factor: 49.962
Authors: Laurent Coudeville; Fabrice Bailleux; Benjamin Riche; Françoise Megas; Philippe Andre; René Ecochard Journal: BMC Med Res Methodol Date: 2010-03-08 Impact factor: 4.615
Authors: Florian Krammer; Randy A Albrecht; Gene S Tan; Irina Margine; Rong Hai; Mirco Schmolke; Jonathan Runstadler; Sarah F Andrews; Patrick C Wilson; Rebecca J Cox; John J Treanor; Adolfo García-Sastre; Peter Palese Journal: J Virol Date: 2014-01-22 Impact factor: 5.103
Authors: Esmeralda Alvarado-Facundo; Russell Vassell; Falko Schmeisser; Jerry P Weir; Carol D Weiss; Wei Wang Journal: PLoS One Date: 2016-02-10 Impact factor: 3.240
Authors: Iuliia M Gilchuk; Sandhya Bangaru; Nurgun Kose; Robin G Bombardi; Andrew Trivette; Sheng Li; Hannah L Turner; Robert H Carnahan; Andrew B Ward; James E Crowe Journal: JCI Insight Date: 2021-10-08